Paliperidone, sold under the trade name Invega among others, is an atypical antipsychotic. Paliperidone is the primary active metabolite of the older antipsychotic risperidone, although its specific mechanism of action with respect to any psychiatric diagnosis is unknown. It blocks the action of dopamine and serotonin in the brain, which as we’ve previously observed is playing Russian Roulette with the brain.
On September 1, 2021 the US Food and Drug Administration (FDA) approved a 6-month injection form of the long-acting atypical antipsychotic paliperidone palmitate (Invega Hafyera, manufactured by Janssen Pharmaceuticals) for the treatment of what is fraudulently diagnosed as schizophrenia in adults.
Adverse reactions, or side effects, can include upper respiratory tract infection, neuroleptic malignant syndrome, seizures, high blood sugar, diabetes, decreased blood pressure, fainting, falls, low white blood cell count, headache, tachycardia, somnolence, insomnia, sexual dysfunction, cough, dystonia, akathisia, muscle rigidity, parkinsonism, weight gain, anxiety, indigestion, constipation, and an increased risk of death in elderly people with dementia-related psychosis.
It can be addictive and have acute withdrawal symptoms (euphemistically called “discontinuation syndrome”), including rapid relapse, nausea, vomiting, loss of appetite, restlessness, increased sweating, trouble sleeping, a feeling of the world spinning, numbness, muscle pains, tardive dyskinesia, and psychosis.
The primary reason for prescribing a drug that has only two doses per year is to handle the situation where a patient stops taking their daily prescribed drugs because of their unpleasant side effects.
Psychiatric Fraud
Psychiatrists remain committed to calling “schizophrenia” a mental disorder despite, after a century of research, the complete absence of objective proof that it exists as a physical brain abnormality.
Psychiatry clings tenaciously to antipsychotics as the treatment for “schizophrenia,” despite their proven risks and studies which show that when patients stop taking these drugs, they improve.
The late Professor Thomas Szasz stated that “schizophrenia is defined so vaguely that, in actuality, it is a term often applied to almost any kind of behavior of which the speaker disapproves.”
These are normal people with medical, disciplinary, educational, or spiritual problems that can and must be resolved without recourse to drugs. Deceiving and drugging is not the practice of medicine. It is criminal.
Bear in mind that the drug “treatments” being prescribed are for “disorders” that are not physical illnesses—essentially, they are being prescribed for something that does not exist.
Any medical doctor who takes the time to conduct a thorough physical examination of a child or adult exhibiting signs of what a psychiatrist calls Schizophrenia can find undiagnosed, untreated physical conditions. Any person labeled with so-called Schizophrenia needs to receive a thorough physical examination by a competent medical—not psychiatric—doctor to first determine what underlying physical condition is causing the manifestation.
Any person falsely diagnosed as mentally disordered which results in treatment that harms them should file a complaint with the police and professional licensing bodies and have this investigated. They should seek legal advice about filing a civil suit against any offending psychiatrist and his or her hospital, associations and teaching institutions seeking compensation.
No one denies that people can have difficult problems in their lives, that at times they can be mentally unstable, subject to unreasonable depression, anxiety or panic. Mental health care is therefore both valid and necessary. However, the emphasis must be on workable mental healing methods that improve and strengthen individuals and thereby society by restoring people to personal strength, ability, competence, confidence, stability, responsibility and spiritual well–being. Psychiatric drugs and psychiatric treatments are not workable.
